Suiza - alemán - Swissmedic (Swiss Agency for Therapeutic Products)

organon gmbh - betamethasonum - injektionssuspension - betamethasonum 5 mg ut betamethasoni dipropionas, betamethasonum 2 mg ut betamethasoni natrii phosphas, dinatrii phosphas dihydricus, natrii chloridum, dinatrii edetas, polysorbatum 80, carmellosum natricum, macrogolum 3350, conserv.: propylis parahydroxybenzoas 0.2 mg, e 218 1.3 mg, alcohol benzylicus 9 mg, aqua ad iniectabile q.s. ad suspensionem pro 1 ml. - intramuskuläre und lokale glukokortikosteroid-therapie - synthetika

Suiza - alemán - Swissmedic (Swiss Agency for Therapeutic Products)

organon gmbh - betamethasonum - injektionssuspension (fertigspritze) - betamethasonum 5 mg ut betamethasoni dipropionas, betamethasonum 2 mg ut betamethasoni natrii phosphas, dinatrii phosphas dihydricus, natrii chloridum, dinatrii edetas, polysorbatum 80, carmellosum natricum, macrogolum 3350, conserv.: propylis parahydroxybenzoas 0.2 mg, e 218 1.3 mg, alcohol benzylicus 9 mg, aqua ad iniectabile q.s. ad suspensionem pro 1 ml. - intramuskuläre und lokale glukokortikosteroid-therapie - synthetika

Suiza - alemán - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - rilpivirinum - depot-injektionssuspension - rilpivirinum 600 mg, poloxamerum 338, glucosum monohydricum, natrii dihydrogenophosphas monohydricus, acidum citricum monohydricum, natrii hydroxidum, aqua ad iniectabile q.s. ad suspensionem pro 2 ml corresp. natrium 1.66 mg. - hiv-infektion - synthetika

Suiza - alemán - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - rilpivirinum - depot-injektionssuspension - rilpivirinum 900 mg, poloxamerum 338, glucosum monohydricum, natrii dihydrogenophosphas monohydricus, acidum citricum monohydricum, natrii hydroxidum, aqua ad iniectabile q.s. ad suspensionem pro 3 ml corresp. natrium 2.49 mg. - hiv-infektion - synthetika

Suiza - alemán - Swissmedic (Swiss Agency for Therapeutic Products)

bencard ag - pollinis allergeni extract - injektionssuspension in einer fertigspritze - a): pollinis allergeni extractum 300 u. ut pollinis allergeni extractum (alnus spp.) et pollinis allergeni extractum (betula spp.) et pollinis allergeni extractum (corylus spp.), tyrosinum, phenolum, natrii chloridum, glycerolum, dinatrii phosphas dodecahydricus et natrii dihydrogenophosphas dihydricus, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.86 mg. b): pollinis allergeni extractum 800 u. ut pollinis allergeni extractum (alnus spp.) et pollinis allergeni extractum (betula spp.) et pollinis allergeni extractum (corylus spp.), tyrosinum, phenolum, natrii chloridum, glycerolum, dinatrii phosphas dodecahydricus et natrii dihydrogenophosphas dihydricus, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.86 mg. c): pollinis allergeni extractum 2000 u. ut pollinis allergeni extractum (alnus spp.) et pollinis allergeni extractum (betula spp.) et pollinis allergeni extractum (corylus spp.), tyrosinum, phenolum, natrii chloridum, glycerolum, dinatrii phosphas dodecahydricus et natrii dihydrogenophosphas dihydricus, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.86 mg. - hyposensibilisierung - allergen: therapeutikum

Suiza - alemán - Swissmedic (Swiss Agency for Therapeutic Products)

gebro pharma ag - triamcinoloni hexacetonidum - injektionssuspension - triamcinoloni hexacetonidum 20 mg, polysorbatum 80, sorbitolum liquidum non cristallisabile, conserv.: alcohol benzylicus 9 mg, aqua ad iniectabile q.s. ad suspensionem pro 1 ml. - entzündliche und degenerative gelenkerkrankungen - synthetika

Suiza - alemán - Swissmedic (Swiss Agency for Therapeutic Products)

bencard ag - pollinis allergeni extract - injektionssuspension in durchstechflaschen - a): pollinis allergeni extractum 600 u. ut pollinis allergeni extractum (alnus spp.) et pollinis allergeni extractum (betula spp.) et pollinis allergeni extractum (corylus spp.), tyrosinum, phenolum, natrii chloridum, glycerolum, dinatrii phosphas dodecahydricus et natrii dihydrogenophosphas dihydricus, aqua ad iniectabile q.s. ad suspensionem pro 1 ml corresp. natrium 3.72 mg. b): pollinis allergeni extractum 1600 u. ut pollinis allergeni extractum (alnus spp.) et pollinis allergeni extractum (betula spp.) et pollinis allergeni extractum (corylus spp.), tyrosinum, phenolum, natrii chloridum, glycerolum, dinatrii phosphas dodecahydricus et natrii dihydrogenophosphas dihydricus, aqua ad iniectabile q.s. ad suspensionem pro 1 ml corresp. natrium 3.72 mg. c): pollinis allergeni extractum 4000 u. ut pollinis allergeni extractum (alnus spp.) et pollinis allergeni extractum (betula spp.) et pollinis allergeni extractum (corylus spp.), tyrosinum, phenolum, natrii chloridum, glycerolum, dinatrii phosphas dodecahydricus et natrii dihydrogenophosphas dihydricus, aqua ad iniectabile q.s. ad suspensionem pro 1 ml corresp. natrium 3.72 mg. - hyposensibilisierung - allergen: therapeutikum

Suiza - alemán - Swissmedic (Swiss Agency for Therapeutic Products)

bencard ag - pollinis allergeni extract - injektionssuspension in einer fertigspritze - a): pollinis allergeni extractum 300 u. ut pollinis allergeni extractum (agrostis capillaris) et pollinis allergeni extractum (alopecurus pratensis) et pollinis allergeni extractum (anthoxanthum odoratum) et pollinis allergeni extractum (arrhenatherum elatius) et pollinis allergeni extractum (bromus spp.) et pollinis allergeni extractum (cynosurus cristatus) et pollinis allergeni extractum (dactylis glomerata) et pollinis allergeni extractum (festuca pratensis) et pollinis allergeni extractum (holcus lanatus) et pollinis allergeni extractum (lolium perenne) et pollinis allergeni extractum (phleum pratense) et pollinis allergeni extractum (poa pratensis) et pollinis allergeni extractum (secale cereale), tyrosinum, phenolum, natrii chloridum, glycerolum, dinatrii phosphas dodecahydricus et natrii dihydrogenophosphas dihydricus, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.86 mg. b): pollinis allergeni extractum 800 u. ut pollinis allergeni extractum (agrostis capillaris) et pollinis allergeni extractum (alopecurus pratensis) et pollinis allergeni extractum (anthoxanthum odoratum) et pollinis allergeni extractum (arrhenatherum elatius) et pollinis allergeni extractum (bromus spp.) et pollinis allergeni extractum (cynosurus cristatus) et pollinis allergeni extractum (dactylis glomerata) et pollinis allergeni extractum (festuca pratensis) et pollinis allergeni extractum (holcus lanatus) et pollinis allergeni extractum (lolium perenne) et pollinis allergeni extractum (phleum pratense) et pollinis allergeni extractum (poa pratensis) et pollinis allergeni extractum (secale cereale), tyrosinum, phenolum, natrii chloridum, glycerolum, dinatrii phosphas dodecahydricus et natrii dihydrogenophosphas dihydricus, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.86 mg. c): pollinis allergeni extractum 2000 u. ut pollinis allergeni extractum (agrostis capillaris) et pollinis allergeni extractum (alopecurus pratensis) et pollinis allerg - subkutane hyposensibilisierung - allergen: therapeutikum

Suiza - alemán - Swissmedic (Swiss Agency for Therapeutic Products)

bavarian nordic switzerland ag - enzephalitidis japanen an viri-antigen fall (stamm: sa-14-2) - injektionssuspension - enzephalitidis japanensis viri antigenum (stamm: sa-14-2) 6.0 u., aluminium ut aluminii hydroxidum hydricum ad adsorptionem, kalii dihydrogenophosphas, dinatrii phosphas, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. kalium 21 µg, natrium 1.9 mg. - aktive immunisierung gegen japanese encephalitis, ab dem vollendeten 18. lebensjahr - impfstoffe

Suiza - alemán - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - haemagglutininum influenzae a (h1n1) (virus stamm a/michigan/45/2015 (h1n1)-like: reassortant virus ivr-180 derived from a/singapore/gp1908/2015), haemagglutininum influenzae a (h3n2) (virus stamm a/hong kong/4801/2014 (h3n2)-like: reassortant virus nymc x-263b ), haemagglutininum influenzae b (virus stamm b/phuket/3073/2013 (yamagata lineage)) - injektionssuspension - haemagglutininum influenzae a (h1n1) (virus stamm a/michigan/45/2015 (h1n1)-like: reassortant virus ivr-180 derived from a/singapore/gp1908/2015) 15 µg, haemagglutininum influenzae a (h3n2) (virus stamm a/hong kong/4801/2014 (h3n2)-like: reassortant virus nymc x-263b ) 15 µg, haemagglutininum influenzae b (virus stamm b/phuket/3073/2013 (yamagata lineage)) 15 µg, haemagglutininum influenzae b (virus stamm b/brisbane/60/2008 (victoria lineage)) 15 µg, polysorbatum 80, octoxinolum-10, natrii chloridum, magnesii chloridum hexahydricum, dinatrii phosphas dodecahydricus, kalii dihydrogenophosphas, kalii chloridum, alfa-tocopheroli hydrogenosuccinas, residui: ovalbuminum max. 0.05 µg, formaldehydum max. 5 µg, natrii desoxycholas max. 65 µg, gentamicini sulfas nihil, hydrocortisonum nihil, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. - aktive immunisierung gegen influenza, ab 36 monaten - impfstoffe